Who owns Affimed Therapeutics B V?
- Ticker: AFMD
- CUSIP Number: n01045108
Tip: Access positions for across all investors
Analyze quarterly positions in Affimed Therapeutics B V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Affimed Therapeutics B V stock
Who bought or sold Affimed Therapeutics B V this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Ridgeback Capital Investments | 15M | $9.3M | 100% | Dec 2023 |
|
683 Capital Management | 7.0M | $4.4M | -15% | Dec 2023 |
|
NEA Management Company | 4.4M | $2.8M | 0% | Dec 2023 |
|
Point72 Asset Management | 4.2M | $2.6M | 0% | Dec 2023 |
|
Millennium Management | 2.0M | $1.3M | -34% | Dec 2023 |
|
Eversept Partners | 1.7M | $801k | 0% | Sep 2023 |
|
FMR | 1.4M | $692k | 0% | Sep 2023 |
|
Vanguard Group | 1.4M | $881k | 0% | Dec 2023 |
|
BlackRock | 1.2M | $550k | -6% | Sep 2023 |
|
Verition Fund Management | 1.1M | $520k | 40% | Sep 2023 |
|
Morgan Stanley | 1.1M | $502k | 45% | Sep 2023 |
|
UBS O'Connor | 820k | $392k | 141% | Sep 2023 |
|
Two Sigma Advisers | 690k | $431k | -7% | Dec 2023 |
|
Kennedy Capital Management | 632k | $395k | 100% | Dec 2023 |
|
Two Sigma Investments | 632k | $395k | -16% | Dec 2023 |
|
Marshall Wace | 607k | $383k | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 572k | $358k | 40% | Dec 2023 |
|
State Street Corporation | 517k | $247k | -8% | Sep 2023 |
|
Intellectus Partners | 410k | $257k | 3% | Dec 2023 |
|
Nan Fung Group Holdings | 373k | $178k | 0% | Sep 2023 |
|
Alyeska Investment Group | 350k | $219k | 0% | Dec 2023 |
|
Standard Life Aberdeen | 209k | $130k | 100% | Dec 2023 |
|
Commonwealth Equity Services | 205k | $128k | 264% | Dec 2023 |
|
Renaissance Technologies | 163k | $78k | -72% | Sep 2023 |
|
Ewa | 143k | $78k | 100% | Dec 2023 |
|
Wells Fargo & Company | 140k | $87k | -14% | Dec 2023 |
|
Geode Capital Management | 136k | $65k | 0% | Sep 2023 |
|
Acadian Asset Management | 110k | $51k | -48% | Sep 2023 |
|
Brown Advisory Holdings Incorporated | 90k | $56k | 0% | Dec 2023 |
|
Two Sigma Securities | 84k | $52k | 6% | Dec 2023 |
|
Squarepoint Ops | 80k | $50k | 336% | Dec 2023 |
|
Barclays | 75k | $48k | 0% | Dec 2023 |
|
Citadel Advisors | 75k | $47k | 17% | Dec 2023 |
|
Harbor Investment Advisory | 59k | $37k | -3% | Dec 2023 |
|
Jane Street | 57k | $36k | -56% | Dec 2023 |
|
LMR Partners | 51k | $32k | 0% | Dec 2023 |
|
Advisor Group Holdings | 42k | $26k | -19% | Dec 2023 |
|
LPL Financial | 41k | $20k | -3% | Sep 2023 |
|
Tower Research Capital | 41k | $20k | 97% | Sep 2023 |
|
Cubist Systematic Strategies | 40k | $25k | -51% | Dec 2023 |
|
Royal Bank of Canada | 38k | $0 | -12% | Dec 2023 |
|
Goldman Sachs Group | 27k | $17k | -51% | Dec 2023 |
|
Cresset Asset Management | 27k | $13k | 0% | Sep 2023 |
|
Us Bancorp | 24k | $15k | 0% | Dec 2023 |
|
Qube Research & Technologies | 20k | $9.7k | -91% | Sep 2023 |
|
Susquehanna International | 19k | $8.9k | -81% | Sep 2023 |
|
Cetera Investment Advisers | 15k | $7.2k | 0% | Sep 2023 |
|
Clear Harbor Asset Management | 15k | $8.2k | 0% | Dec 2023 |
|
Bank Of Montreal | 14k | $8.5k | -7% | Dec 2023 |
|
Dimensional Fund Advisors | 13k | $8.3k | -88% | Dec 2023 |
|
HighTower Advisors | 11k | $7.0k | 100% | Dec 2023 |
|
A. Montag and Associates | 10k | $6.3k | 100% | Dec 2023 |
|
Pnc Financial Services | 6.0k | $3.8k | 0% | Dec 2023 |
|
Group One Trading | 4.8k | $2.3k | -20% | Sep 2023 |
|
Point72 Asia | 4.2k | $2.6k | 100% | Dec 2023 |
|
Bank of America Corporation | 1.8k | $902.000000 | -60% | Dec 2023 |
|
Newbridge Financial Services Group | 1.5k | $717.000000 | 0% | Sep 2023 |
|
IFP Advisors | 1.2k | $718.980000 | 0% | Dec 2023 |
|
Wetzel Investment Advisors | 1.0k | $1.0k | 100% | Dec 2023 |
|
Simplex Trading | 900.00 | $0 | -23% | Dec 2023 |
|
Ronald Blue Trust | 335.00 | $0 | 100% | Dec 2023 |
|
Toronto-Dominion Bank | 285.00 | $136.002000 | 100% | Sep 2023 |
|
Jpmorgan Chase & Co | 199.00 | $123.996900 | -99% | Dec 2023 |
|
Parkside Financial Bank & Trust | 150.00 | $94.005000 | 100% | Dec 2023 |
|
Citigroup | 122.00 | $77.640800 | -94% | Dec 2023 |
|
Cape Investment Advisory | 100.00 | $63.000000 | 0% | Dec 2023 |
|
Who sold out of Affimed Therapeutics B V?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Baker Bros. Advisors | Sep 2023 | 4.4M | $2.1M |
VR Adviser | Sep 2023 | 1.4M | $683k |
Y-Intercept | Jun 2023 | 216k | $129k |
Ergoteles | Jun 2023 | 141k | $85k |
Old Mission Capital | Jun 2023 | 80k | $48k |
Vident Investment Advisory | Jun 2023 | 17k | $10k |
Balyasny Asset Management | Sep 2023 | 10k | $4.8k |
China Universal Asset Management | Sep 2023 | 3.8k | $2.0k |
Daiwa Securities Group | Sep 2023 | 407.00 | $0 |